Acrivon Therapeutics
ACRV
#9607
Rank
$42.32 M
Marketcap
$1.35
Share price
-2.88%
Change (1 day)
-77.16%
Change (1 year)

Revenue for Acrivon Therapeutics (ACRV)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acrivon Therapeutics from 2022 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A